SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-18-015648
Filing Date
2018-06-15
Accepted
2018-06-14 20:02:43
Documents
10
Period of Report
2018-06-11
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.05: Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K 2018 ANNUAL MEETING RESULTS sgmo-8k_20180611.htm 8-K 100128
2 EX-3.1 sgmo-ex31_6.htm EX-3.1 114313
3 EX-14.1 sgmo-ex141_13.htm EX-14.1 75414
4 EX-99.2 sgmo-ex992_12.htm EX-99.2 40666
5 EX-99.3 sgmo-ex993_11.htm EX-99.3 37294
6 EX-99.4 sgmo-ex994_10.htm EX-99.4 45624
7 EX-99.5 sgmo-ex995_9.htm EX-99.5 29542
8 EX-99.6 sgmo-ex996_7.htm EX-99.6 29853
9 EX-99.7 sgmo-ex997_8.htm EX-99.7 39339
10 GRAPHIC g201806142135302955126.jpg GRAPHIC 4418
  Complete submission text file 0001564590-18-015648.txt   520075
Mailing Address 501 CANAL BLVD POINT RICHMOND TECH CNTR. RICHMOND CA 94804
Business Address 501 CANAL BLVD POINT RICHMOND TECH CNTR. RICHMOND CA 94804 5109706000
SANGAMO THERAPEUTICS, INC (Filer) CIK: 0001001233 (see all company filings)

IRS No.: 680359556 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30171 | Film No.: 18900505
SIC: 2836 Biological Products, (No Diagnostic Substances)